Trial Outcomes & Findings for Unicirc Adolescent 12-15 Year Old Boys (NCT NCT02593630)

NCT ID: NCT02593630

Last Updated: 2019-02-04

Results Overview

Duration from placement of instrument to dressing

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

54 participants

Primary outcome timeframe

Intraoperative, 10-15 minutes

Results posted on

2019-02-04

Participant Flow

Participant milestones

Participant milestones
Measure
Unicirc Circumcision
Unicirc circumcision: Unicirc circumcision under topical (EMLA) anaesthesia, wound sealing with cyanoacrylate tissue adhesive
Overall Study
STARTED
54
Overall Study
COMPLETED
53
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Unicirc Adolescent 12-15 Year Old Boys

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Unicirc Circumcision
n=54 Participants
Unicirc circumcision: Unicirc circumcision under topical (EMLA) anaesthesia, wound sealing with cyanoacrylate tissue adhesive
Age, Categorical
<=18 years
54 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
Sex: Female, Male
Male
54 Participants
n=5 Participants
Region of Enrollment
South Africa
54 participants
n=5 Participants

PRIMARY outcome

Timeframe: Intraoperative, 10-15 minutes

Duration from placement of instrument to dressing

Outcome measures

Outcome measures
Measure
Unicirc Circumcision
n=54 Participants
Unicirc circumcision: Unicirc circumcision under topical (EMLA) anaesthesia, wound sealing with cyanoacrylate tissue adhesive
Intraoperative Duration
9.5 minutes
Interval 9.5 to 10.0

SECONDARY outcome

Timeframe: Time of surgery, approximately 10-15 minutes

Intraoperative pain, measured on a standard 10 point pain scale (0=no pain, 5=moderate pain, 10 severe pain) using a pain face diagram.

Outcome measures

Outcome measures
Measure
Unicirc Circumcision
n=54 Participants
Unicirc circumcision: Unicirc circumcision under topical (EMLA) anaesthesia, wound sealing with cyanoacrylate tissue adhesive
Intraoperative Pain
1 units on a scale (0 - 10)
Interval 0.5 to 1.5

SECONDARY outcome

Timeframe: At the 4-week followup visit

Number of participants that are fully healed (epithelialized, no superficial ulcerations) at 4 weeks.

Outcome measures

Outcome measures
Measure
Unicirc Circumcision
n=53 Participants
Unicirc circumcision: Unicirc circumcision under topical (EMLA) anaesthesia, wound sealing with cyanoacrylate tissue adhesive
Healed at 4 Weeks
53 Participants

Adverse Events

Unicirc Circumcision

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Unicirc Circumcision
n=54 participants at risk
Unicirc circumcision: Unicirc circumcision under topical (EMLA) anaesthesia, wound sealing with cyanoacrylate tissue adhesive
Reproductive system and breast disorders
Bleeding, hematoma, infection, wound dehiscence
0.00%
0/54 • 1 month
We looked for intra-operative or post-operative bleeding, hematoma, infection, poor cosmetic result, wound dehiscence. None of these or other events occurred.

Additional Information

Peter S. Millard, MD, Phd

University of New England

Phone: 2072992131

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place